PH21329A - Dihydropyridine anti-ischaemic and antihypertensive agent - Google Patents

Dihydropyridine anti-ischaemic and antihypertensive agent

Info

Publication number
PH21329A
PH21329A PH31741A PH31741A PH21329A PH 21329 A PH21329 A PH 21329A PH 31741 A PH31741 A PH 31741A PH 31741 A PH31741 A PH 31741A PH 21329 A PH21329 A PH 21329A
Authority
PH
Philippines
Prior art keywords
ischaemic
antihypertensive agent
dihydropyridine anti
dihydropyridine
antihypertensive
Prior art date
Application number
PH31741A
Other languages
English (en)
Inventor
Alker David
Cross Peter Edward
Campbell Simon Fraser
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH21329A publication Critical patent/PH21329A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
PH31741A 1984-01-18 1985-01-18 Dihydropyridine anti-ischaemic and antihypertensive agent PH21329A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848401288A GB8401288D0 (en) 1984-01-18 1984-01-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
PH21329A true PH21329A (en) 1987-10-13

Family

ID=10555153

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31741A PH21329A (en) 1984-01-18 1985-01-18 Dihydropyridine anti-ischaemic and antihypertensive agent

Country Status (15)

Country Link
US (1) US4548935A (da)
EP (1) EP0150939A1 (da)
JP (1) JPS60161981A (da)
KR (1) KR870000912B1 (da)
AU (1) AU556636B2 (da)
DK (1) DK21785A (da)
ES (1) ES8604928A1 (da)
FI (1) FI850199A7 (da)
GB (1) GB8401288D0 (da)
HU (1) HU193918B (da)
IL (1) IL74071A0 (da)
PH (1) PH21329A (da)
PL (1) PL143334B1 (da)
PT (1) PT79830B (da)
YU (1) YU7685A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233228A1 (en) * 1985-08-06 1987-08-26 Boehringer Mannheim Italia S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 1,4−ジヒドロピリジン誘導体
IE64995B1 (en) * 1987-07-14 1995-09-20 Warner Lambert Co Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
SE0200979D0 (sv) * 2002-03-28 2002-03-28 Astrazeneca Ab New compounds
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
JP2011506315A (ja) * 2007-12-05 2011-03-03 バイアル−ポルテラ アンド シーエー,エス.エー. 新たな塩、及び結晶形

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
JPS57175166A (en) * 1981-04-23 1982-10-28 Banyu Pharmaceut Co Ltd Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation
EP0100189B1 (en) * 1982-07-22 1986-05-28 Pfizer Limited Dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
HUT37755A (en) 1986-02-28
FI850199L (fi) 1985-07-19
ES539592A0 (es) 1986-02-16
DK21785A (da) 1985-07-19
KR850005438A (ko) 1985-08-26
PT79830A (en) 1985-02-01
DK21785D0 (da) 1985-01-17
PL143334B1 (en) 1988-02-29
ES8604928A1 (es) 1986-02-16
PT79830B (en) 1986-12-09
PL251584A1 (en) 1985-12-03
GB8401288D0 (en) 1984-02-22
KR870000912B1 (ko) 1987-05-06
US4548935A (en) 1985-10-22
FI850199A7 (fi) 1985-07-19
HU193918B (en) 1987-12-28
FI850199A0 (fi) 1985-01-16
AU556636B2 (en) 1986-11-13
YU7685A (en) 1987-10-31
EP0150939A1 (en) 1985-08-07
AU3775185A (en) 1985-07-25
IL74071A0 (en) 1985-04-30
JPS60161981A (ja) 1985-08-23

Similar Documents

Publication Publication Date Title
AU546634B2 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
GB2176514B (en) Building structure and components thereof
ZA855563B (en) Glutarimide antianxiety and antihypertensive agents
GB2158065B (en) Dihydropyridines
GB2162513B (en) Dihydropyridine derivatives
ZA874257B (en) Antihypertensive dihydropyridine derivatives
PH15278A (en) Antihypertensive pyridines and compositions
AU566026B2 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
DE3567460D1 (en) Dihydropyridines
IL75427A0 (en) Dihydropyridines and pharmaceutical compositions containing them
GR860384B (en) Antihypertensive dihydropyridine derivatives
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
ZA86966B (en) Antihypertensive dihydropyridine derivatives
AU574003B2 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
AU565318B2 (en) Dihydropyridine anti-ischaemic and anti-hypertensive agents
ZA845619B (en) Dihydropyridine anti-ischaemic and antihypertensive agents
PT80630A (en) Process for preparing dihydropyridine anti-ischaemic and antihypertensive agents
ZA854665B (en) Dihydropyridine derivatives
PH18785A (en) Dihoydropyridine anti-ischaemic and antihypertensive agents and pharmaceutical compositions containing them
ZA856396B (en) Building components and constructions
GB8414520D0 (en) Dihydropyridines
IE841548L (en) Dihydropyridines